SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Nymox Pharmaceutical Corp. & Its Board of...
December 29 2014 - 04:31PM
Business Wire
Levi & Korsinsky announces that a class action lawsuit has
been commenced in the United States District Court for the District
of New Jersey on behalf of investors who purchased Nymox
Pharmaceutical Corporation (“Nymox” or the “Company”) (Nasdaq:NYMX)
securities between January 31, 2011 and November 2, 2014.
For more information, click here:
http://zlk.9nl.com/nymox-pharmaceutical-nymx.
The complaint alleges that Nymox failed to disclose material
information affecting the Phase 3 clinical trials for it’s
proprietary drug NX-1207 for the treatment of benign prostatic
hyperplastic (BPH).
On November 2, 2014, Nymox disclosed that the Company’s two
Phase 3 studies had to be halted because the drug failed to meet
its primary endpoints for efficacy. The following day, Nymox
disclosed to the market for the first time, among other things, the
difficulties faced in enrolling men for the trials, and the
subjective nature of the measurement of the drug’s success.
If you suffered a loss in Nymox you have until January 26, 2015
to request that the Court appoint you as lead plaintiff. Your
ability to share in any recovery doesn’t require that you serve as
a lead plaintiff. To obtain additional information, contact Joseph
E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at
(212) 363-7500, toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/nymox-pharmaceutical-nymx.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits and
have helped shareholders recover millions of dollars in losses over
the years. For more information, please feel free to contact any of
the attorneys listed below. Attorney advertising. Prior results do
not guarantee similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Mar 2023 to Mar 2024